Jubilant Life Sciences reported 92 per cent year on year (YoY) jump in normalised profit after tax at Rs 260 crore in Q4FY20. Ebitda margin also improved to 23.7 per cent from 16.3 per cent in Q4FY19.
Jubilant Life Sciences reported 92 per cent year on year (YoY) jump in normalised profit after tax at Rs 260 crore in Q4FY20. Ebitda margin also improved to 23.7 per cent from 16.3 per cent in Q4FY19.